false000082718700008271872023-11-022023-11-02

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  November 2, 2023 
SNBR Logo JPG.jpg
SLEEP NUMBER CORPORATION
(Exact name of registrant as specified in its charter)

Minnesota
(State or other jurisdiction of incorporation)
000-2512141-1597886
(Commission File Number)(IRS Employer Identification No.)

1001 Third Avenue South, Minneapolis, MN  55404
(Address of principal executive offices) (Zip Code) 
(763) 551-7000
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading
Symbol(s)
 Name of each exchange on which registered
Common Stock, par value $0.01 per share SNBR Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 
Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  



ITEM 1.01ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
On November 2, 2023, Sleep Number Corporation, a Minnesota corporation (“Sleep Number”), entered into a Tenth Amendment (the “Tenth Amendment”) amending and supplementing the Amended and Restated Credit and Security Agreement, dated as of February 14, 2018 (as amended, supplemented or otherwise modified from time to time, including by the Ninth Amendment, the “Credit Agreement”), among U.S. Bank National Association (“U.S. Bank”), as Administrative Agent, Swing Line Lender and Issuing Lender, and certain other financial institutions party thereto.

The Tenth Amendment, among other things, (a) decreases the total aggregate commitment under the Credit Agreement from $825 million to $685 million, (b) decreases the $625 million revolving loan commitment to $485 million, (c) decreases the accordion from $400 million to $342.5 million, (d) increases the Applicable Commitment Fee Rate to 50 basis points when the Net Leverage Ratio is greater than or equal to 3.50 to 1.00 (as each is defined in the Credit Agreement), (e) increases the Applicable Margin by 25 to 75 basis points for each respective range of Net Leverage Ratios (as each is defined in the Credit Agreement), (f) deems our Net Leverage Ratio as greater than or equal to 4.00 to 1.00 but less than 4.50 to 1.00 as of the Tenth Amendment effective date to set pricing for the Applicable Commitment Fee Rate and Applicable Margin until receipt of the compliance certificate for the quarterly reporting period ending December 30, 2023, (g) amends the definition of Consolidated EBITDA (as defined in the Credit Agreement) to include cash add backs, capped at $30 million for the quarterly reporting periods ending December 30, 2023, March 30, 2024, June 29, 2024, September 28, 2024, and December 28, 2024 and capped at $20 million for each quarterly reporting period ending thereafter, (h) amends the definitions of each of Net Leverage Ratio and Senior Secured Leverage Ratio (as each is defined in the Credit Agreement) to include the total operating lease liabilities of borrower, as calculated in accordance with ASC 842 accounting guidance (as of the end of the most recently completed quarterly reporting period) replacing the prior language of six multiplied by Consolidated Rent Expense (for the most recently completed four quarterly reporting periods), (i) adjusts the permissible maximum Net Leverage Ratio (as defined in the Credit Agreement) to (I) 5.00 to 1.00 for the quarterly reporting periods ending December 30, 2023 and March 30, 2024, (II) 5.50 to 1.00 for the quarterly reporting period ending June 29, 2024, (III) 5.00 to 1.00 for the quarterly reporting period ending September 28, 2024, (IV) 4.80 to 1.00 for the quarterly reporting period ending December 28, 2024, and (V) 4.00 to 1.00 for each quarterly reporting period occurring thereafter, (j) adjusts the permissible maximum Interest Coverage Ratio (as defined in the Credit Agreement) to (I) 1.50 to 1.00 for the quarterly reporting periods ending December 30, 2023 and March 30, 2024, (II) 1.25 to 1.00 for the quarterly reporting period ending June 29, 2024, (III) 1.50 to 1.00 for the quarterly reporting periods ending September 28, 2024 and December 28, 2024, and (IV) 3.00 to 1.00 for each quarterly reporting period occurring thereafter, and (k) decreases the requisite Net Leverage Ratio from 3.75 to 1.00 down to 3.00 to 1.00 (under the new applicable definitions) before any Acquisitions (with the exception of the Specified Acquisition) or Restricted Payments (as each is defined in the Credit Agreement) may be made. A fee for the amendment is payable to the approving lenders in an amount equal to 20 basis points multiplied by the sum of such lender's Revolving Credit Commitment and outstanding Term Loans (as each is defined in the Credit Agreement). The foregoing description of the Tenth Amendment is qualified in its entirety by reference to the complete terms of the Tenth Amendment, which Sleep Number will file as an exhibit to its next Quarterly Report on Form 10-Q.

ITEM 2.02RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On November 7, 2023, Sleep Number issued a press release announcing results for the fiscal third quarter ended September 30, 2023. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.


ITEM 2.03CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT

The information under Item 1.01 above is incorporated by reference into this Item 2.03.


ITEM 2.05
COSTS ASSOCIATED WITH EXIT OR DISPOSAL ACTIVITIES
On November 6, 2023, in light of the demand trajectory change in August, the Company initiated business restructuring actions which are expected to reduce 2024 operating expenses by approximately $50 million and accelerate gross margin initiatives, in addition to the approximate $80 million of operating expense reductions expected to be realized in 2023. These actions are broad-based and include a headcount reduction of approximately 10% or 500 team members across all areas of the organization, including in corporate and research and development functions. These actions also include a rationalization of the store portfolio with a planned closure of 40 to 50 stores by the end of 2024, a slower rate of new store openings and remodels, and a reduction of the Company's 2024 capital expenditures. Gross margin improvement actions include value engineering and cost optimization strategies, including driving additional efficiencies through the Company's manufacturing and home delivery network. These business restructuring actions are expected to result in up to $20 million of one-time costs, with an estimated $10 million of the costs being recorded in the fourth quarter of 2023.




The estimates of costs and expenses that the Company expects to incur in connection with the business restructuring actions are subject to a number of assumptions and actual results may differ materially. The Company may also incur additional costs or negative impacts not currently contemplated due to events that may occur as a result of, or that are associated with, these actions.


ITEM 9.01.FINANCIAL STATEMENTS AND EXHIBITS.
(d)    Exhibits.
Exhibit No.Description of Exhibit
99.1
104Cover Page Interactive Data File (embedded within the Inline XBRL document)







SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
  SLEEP NUMBER CORPORATION
  (Registrant)
     
Dated:  November 7, 2023
 By:     /s/ Samuel R. Hellfeld
  Name: Samuel R. Hellfeld
  Title: Executive Vice President, Chief Legal and Risk Officer

Exhibit 99.1
snbrlogojpga.jpg
FOR IMMEDIATE RELEASE

SLEEP NUMBER ANNOUNCES THIRD QUARTER 2023 RESULTS

Third quarter net sales declined 13% versus the prior year to $473 million; third quarter diluted loss per share of $0.10
Initiated approximately $50 million of additional operating expense reduction actions for 2024 on top of an estimated $80 million for 2023
Updated 2023 EPS outlook to a loss of up to $0.70 per share, which includes an estimated $10 million or $0.35 per share of restructuring charges to be recorded in the fourth quarter
Amended and right-sized bank facility to provide additional covenant flexibility through 2024

MINNEAPOLIS – (November 7, 2023) – Sleep Number Corporation (Nasdaq: SNBR) today reported results for the quarter ended September 30, 2023.

“The third quarter was challenging for Sleep Number and the bedding industry as the consumer demand trajectory changed abruptly midway through the quarter,” said Shelly Ibach, Chair, President and CEO, Sleep Number. “In response, we acted quickly to further reduce costs, recalibrate our sales and marketing approach, and amend our credit agreement to provide additional covenant flexibility through the end of 2024. We expect these actions and broad-based restructuring initiatives to result in a more durable operating model with improved profitability and cash flows in a range of economic environments. We remain confident in our strategic direction and ability to deliver superior value creation over time.”

Third Quarter Financial Overview
Net sales decreased 13% to $473 million; demand decelerated abruptly in August and September, leading to a low double-digit demand decline for the quarter versus prior year
Gross margin of 57.4% was up 130 bp versus the prior year, primarily benefiting from pricing actions and easing commodity prices
Operating expenses were reduced by $25 million to $266 million compared with $290 million last year
Loss per diluted share of $0.10 compared with diluted earnings per share of $0.22 last year

Cash Flows Overview
Net cash from operating activities of $32 million for the first nine months of the year, compared with $80 million for the same period last year
Leverage ratio of 4.8x EBITDAR at the end of the third quarter versus covenant maximum of 5.0x
Adjusted ROIC of 14.9% for the trailing twelve months

Business Restructuring Actions
In light of the demand trajectory change in August, the company initiated additional cost reduction actions which are expected to reduce 2024 operating expenses by approximately $50 million, and also accelerated gross margin initiatives. The operating expense reductions are incremental to the $80 million of operating expense reductions we expect to realize in 2023.
The cost restructuring actions are broad-based and include a reduction in headcount across all areas of the organization, including in corporate and R&D functions
We are rationalizing our store portfolio with a planned closure of 40 to 50 stores by the end of 2024, along with slowing the rate of new store openings and remodels, and also reducing our 2024 capital expenditures
Gross margin improvement actions include value engineering and cost optimization strategies, including driving additional efficiencies through our manufacturing and home delivery network
The business restructuring actions are expected to result in up to $20 million of one-time restructuring costs, with an estimated $10 million of the costs being recorded in the fourth quarter of this year

Amended Credit Agreement
The company also amended the financial covenants of the revolving credit facility to provide greater flexibility through 2024, and right-sized the aggregate availability of the credit facility to $685 million
Prospectively, the company will be utilizing a new definition for net leverage as highlighted on page 9 of this news release; our leverage ratio under the new definition was 3.8x EBITDAR at end of the third quarter



Sleep Number Announces Third-quarter 2023 Results - Page 2 of 10    

Financial Outlook
The company updated its full-year 2023 diluted EPS outlook to a loss of up to $0.70 per share. The updated EPS outlook includes an estimated $10 million, or $0.35 per share, of restructuring charges to be recorded in the fourth quarter. The 2023 outlook assumes net sales are down low double digits versus the prior year, with approximately 100 basis points of gross margin rate improvement year-over-year. The company anticipates 2023 capital expenditures of approximately $60 million.

Conference Call Information
Management will host its regularly scheduled conference call to discuss the company’s results at 5 p.m. EST (4 p.m. CST; 2 p.m. PST) today. To access the webcast, visit the investor relations area of the Sleep Number website at https://ir.sleepnumber.com. The webcast replay will remain available for approximately 60 days.

About Sleep Number Corporation
Sleep Number is a wellness technology company. We are guided by our purpose to improve the health and wellbeing of society through higher quality sleep; to date, our innovations have improved over 15 million lives. Our wellness technology platform helps solve sleep problems, whether it’s providing individualized temperature control for each sleeper through our Climate360® smart bed or applying our 23 billion hours of longitudinal sleep data and expertise to research with global institutions.

Our smart bed ecosystem drives best-in-class engagement through dynamic, adjustable, and effortless sleep with personalized digital sleep and health insights; our millions of Smart Sleepers are loyal brand advocates. And our almost 4,500 mission-driven team members passionately innovate to drive value creation through our vertically integrated business model, including our exclusive direct-to-consumer selling in over 650 stores and online.

To learn more about life-changing, individualized sleep, visit a Sleep Number store near you, our newsroom.  and investor relations sites, or SleepNumber.com

Forward-looking Statements
Statements used in this news release relating to future plans, events, financial results or performance, such as the company’s full-year 2023 diluted EPS and future capital expenditures and operating expenses, are forward-looking statements subject to certain risks and uncertainties including, among others, such factors as current and future economic conditions and consumer sentiment; ability to realize expected cost savings and other benefits related to cost restructuring actions and to avoid unexpected adverse effects on the company; increases in interest rates, which have increased the cost of servicing the company’s indebtedness; availability of attractive and cost-effective consumer credit options; the effectiveness of the company’s marketing strategy and promotional efforts; the execution of Sleep Number’s Total Retail distribution strategy; operating with minimal levels of inventory, which may leave the company vulnerable to supply shortages; bank failures or other events affecting financial institutions; Sleep Number’s dependence on, and ability to maintain strong working relationships with key suppliers and third parties; rising commodity costs or third-party logistics costs and other inflationary pressures; risks inherent in global-sourcing activities, including tariffs, geo-political turmoil, war, strikes, labor challenges, government-mandated work closures, outbreaks of pandemics or contagious diseases, and resulting supply shortages and production and delivery delays and disruptions; risks of disruption due to health epidemics or pandemics, such as the COVID-19 pandemic; regional risks related to having global operations and suppliers, including climate and other disasters; ability to achieve and maintain high levels of product quality; ability to improve and expand Sleep Number’s product line and execute successful new product introductions; ability to prevent third parties from using the company’s technology or trademarks, and the adequacy of its intellectual property rights to protect its products and brand; ability to compete; risks of disruption in the operation of any of the company’s main manufacturing, distribution, logistics, home delivery, product development or customer service operations; the company’s ability to comply with existing and changing government regulation; pending or unforeseen litigation and the potential for associated adverse publicity; the adequacy of the company’s and third-party information systems and costs and disruptions related to upgrading or maintaining these systems; the company’s ability to withstand cyber threats that could compromise the security of its systems, result in a data breach or business disruption; Sleep Number’s ability, and the ability of its suppliers and vendors, to attract, retain and motivate qualified personnel; the volatility of Sleep Number stock; environmental, social and governance (ESG) risks, including increasing regulation and stakeholder expectations; and the company’s ability to adapt to climate change and readiness for legal or regulatory responses thereto. Additional information concerning these and other risks and uncertainties is contained in the company’s filings with the Securities and Exchange Commission (SEC), including the Annual Report on Form 10-K, and other periodic reports filed with the SEC. The company has no obligation to publicly update or revise any of the forward-looking statements in this news release.

# # #

Investor Contact: Dave Schwantes; (763) 551-7498; investorrelations@sleepnumber.com
Media Contact: Julie Elepano; julie.elepano@sleepnumber.com


Sleep Number Announces Third-quarter 2023 Results - Page 3 of 10    

SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Statements of Operations
(unaudited – in thousands, except per share amounts)
 
Three Months Ended
 September 30,
2023
% of
Net Sales
October 1,
2022
% of
Net Sales
Net sales$472,648 100.0 %$540,566 100.0 %
Cost of sales201,537 42.6 %237,479 43.9 %
Gross profit271,111 57.4 %303,087 56.1 %
Operating expenses:
Sales and marketing221,143 46.8 %239,656 44.3 %
General and administrative31,948 6.8 %36,003 6.7 %
Research and development12,633 2.7 %14,786 2.7 %
Total operating expenses265,724 56.2 %290,445 53.7 %
Operating income5,387 1.1 %12,642 2.3 %
Interest expense, net10,958 2.3 %5,606 1.0 %
(Loss) Income before income taxes(5,571)(1.2 %)7,036 1.3 %
Income tax (benefit) expense(3,253)(0.7 %)2,003 0.4 %
Net (loss) income$(2,318)(0.5 %)$5,033 0.9 %
Net (loss) income per share – basic$(0.10) $0.23  
Net (loss) income per share – diluted$(0.10) $0.22  
Reconciliation of weighted-average shares outstanding:
Basic weighted-average shares outstanding22,479  22,218  
Dilutive effect of stock-based awards—  355  
Diluted weighted-average shares outstanding22,479  22,573  

For the three months ended September 30, 2023, potentially dilutive stock-based awards have been excluded from the calculation of diluted weighted-average shares outstanding, as their inclusion would have had an anti-dilutive effect on our net loss per diluted share.


Sleep Number Announces Third-quarter 2023 Results - Page 4 of 10    

SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Statements of Operations
(unaudited – in thousands, except per share amounts)
 
 Nine Months Ended
September 30,
2023
% of
Net Sales
October 1,
2022
% of
Net Sales
Net sales$1,457,964 100.0 %$1,616,769 100.0 %
Cost of sales612,343 42.0 %686,439 42.5 %
Gross profit845,621 58.0 %930,330 57.5 %
Operating expenses:
Sales and marketing649,410 44.5 %700,405 43.3 %
General and administrative111,144 7.6 %116,049 7.2 %
Research and development42,521 2.9 %46,908 2.9 %
Total operating expenses803,075 55.1 %863,362 53.4 %
Operating income42,546 2.9 %66,968 4.1 %
Interest expense, net30,008 2.1 %11,352 0.7 %
Income before income taxes12,538 0.9 %55,616 3.4 %
Income tax expense2,637 0.2 %13,576 0.8 %
Net income$9,901 0.7 %$42,040 2.6 %
Net income per share – basic$0.44  $1.87  
Net income per share – diluted$0.44  $1.83  
Reconciliation of weighted-average shares outstanding:
Basic weighted-average shares outstanding22,412  22,444  
Dilutive effect of stock-based awards146  515  
Diluted weighted-average shares outstanding22,558  22,959  



Sleep Number Announces Third-quarter 2023 Results - Page 5 of 10    
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Balance Sheets
(unaudited – in thousands, except per share amounts)
subject to reclassification
  
 September 30,
2023
December 31,
2022
Assets  
Current assets:
Cash and cash equivalents$906 $1,792 
Accounts receivable, net of allowances of $1,408 and $1,267, respectively
18,631 26,005 
Inventories116,224 114,034 
Prepaid expenses21,076 16,006 
Other current assets41,230 39,921 
Total current assets198,067 197,758 
Non-current assets:  
Property and equipment, net190,707 200,605 
Operating lease right-of-use assets401,564 397,755 
Goodwill and intangible assets, net66,690 68,065 
Deferred income taxes21,391 7,958 
Other non-current assets82,616 81,795 
Total assets$961,035 $953,936 
Liabilities and Shareholders’ Deficit  
Current liabilities:  
Borrowings under revolving credit facility$488,000 $459,600 
Accounts payable168,883 176,207 
Customer prepayments45,902 73,181 
Accrued sales returns23,012 25,594 
Compensation and benefits24,281 31,291 
Taxes and withholding27,198 23,622 
Operating lease liabilities83,143 79,533 
Other current liabilities58,907 60,785 
Total current liabilities919,326 929,813 
Non-current liabilities:
Operating lease liabilities356,579 356,879 
Other non-current liabilities105,817 105,421 
Total non-current liabilities462,396 462,300 
Total liabilities1,381,722 1,392,113 
Shareholders’ deficit:
Undesignated preferred stock; 5,000 shares authorized, no shares issued and outstanding
— — 
Common stock, $0.01 par value; 142,500 shares authorized, 22,228 and 22,014 shares issued and outstanding, respectively
222 220 
Additional paid-in capital12,769 5,182 
Accumulated deficit(433,678)(443,579)
Total shareholders’ deficit(420,687)(438,177)
Total liabilities and shareholders’ deficit$961,035 $953,936 



Sleep Number Announces Third-quarter 2023 Results - Page 6 of 10    
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(unaudited – in thousands)
subject to reclassification
 
 Nine Months Ended
 September 30,
2023
October 1,
2022
Cash flows from operating activities:  
Net income$9,901 $42,040 
Adjustments to reconcile net income to net cash provided by
   operating activities:
Depreciation and amortization55,196 49,342 
Stock-based compensation10,872 8,585 
Net loss on disposals and impairments of assets464 274 
Deferred income taxes(13,433)(6,955)
Changes in operating assets and liabilities:
Accounts receivable7,374 (1,029)
Inventories(2,190)(11,080)
Income taxes3,571 4,530 
Prepaid expenses and other assets(5,903)20,082 
Accounts payable5,199 28,889 
Customer prepayments(27,279)(34,225)
Accrued compensation and benefits(6,923)(23,735)
Other taxes and withholding4,744 
Other accruals and liabilities(5,038)(1,340)
Net cash provided by operating activities31,816 80,122 
Cash flows from investing activities:
Purchases of property and equipment(48,022)(52,808)
Proceeds from sales of property and equipment10 49 
Issuance of notes receivable(1,317)— 
Net cash used in investing activities(49,329)(52,759)
Cash flows from financing activities:
Net increase in short-term borrowings20,334 34,781 
Repurchases of common stock(3,711)(64,141)
Proceeds from issuance of common stock428 998 
Debt issuance costs(424)(42)
Net cash provided by (used in) financing activities16,627 (28,404)
Net decrease in cash and cash equivalents(886)(1,041)
Cash and cash equivalents, at beginning of period1,792 2,389 
Cash and cash equivalents, at end of period$906 $1,348 



Sleep Number Announces Third-quarter 2023 Results - Page 7 of 10    
SLEEP NUMBER CORPORATION
AND SUBSIDIARIES
Supplemental Financial Information
(unaudited)
 
 Three Months EndedNine Months Ended
 September 30,
2023
October 1,
2022
September 30,
2023
October 1,
2022
Percent of sales:    
Retail stores86.6 %86.3 %87.1 %86.7 %
Online, phone, chat and other13.4 %13.7 %12.9 %13.3 %
Total Company100.0 %100.0 %100.0 %100.0 %
Sales change rates:
Retail comparable-store sales(14 %)(21 %)(11 %)(10 %)
Online, phone and chat(14 %)%(13 %)%
Total Retail comparable sales change(14 %)(18 %)(11 %)(8 %)
 Net opened/closed stores and other
%%%%
Total Company(13 %)(16 %)(10 %)(5 %)
Stores open:
Beginning of period672 659 670 648 
Opened12 27 35 
Closed(2)(9)(19)(21)
End of period678 662 678 662 
Other metrics:
Average sales per store ($ in 000's) 1
$2,952 $3,302 
Average sales per square foot 1
$963 $1,093 
Stores > $2 million net sales 2
67 %77 %
Stores > $3 million net sales 2
27 %38 %
Average revenue per smart bed unit 3
$5,640 $5,083 $5,822 $5,416 

1 Trailing twelve months Total Retail comparable sales per store open at least one year.
2 Trailing twelve months for stores open at least one year (excludes online, phone and chat sales).
3 Represents Total Retail (stores, online, phone and chat) net sales divided by Total Retail smart bed units.


Sleep Number Announces Third-quarter 2023 Results - Page 8 of 10    
SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)
(in thousands)

We define earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net income plus: income tax expense, interest expense, depreciation and amortization, stock-based compensation and asset impairments. Management believes Adjusted EBITDA is a useful indicator of our financial performance and our ability to generate cash from operating activities. Our definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure:
 Three Months EndedTrailing Twelve Months Ended
 September 30,
2023
October 1,
2022
September 30,
2023
October 1,
2022
Net (loss) income$(2,318)$5,033 $4,471 $53,181 
Income tax (benefit) expense(3,253)2,003 1,346 15,247 
Interest expense10,958 5,606 37,641 13,196 
Depreciation and amortization18,200 17,180 72,338 64,217 
Stock-based compensation982 542 15,511 12,097 
Asset impairments292 95 491 338 
Adjusted EBITDA$24,861 $30,459 $131,798 $158,276 
 

Free Cash Flow
(in thousands)
 Three Months EndedTrailing Twelve Months Ended
 September 30,
2023
October 1,
2022
September 30,
2023
October 1,
2022
Net cash provided by (used in) by operating activities
$13,096 $51,431 $(12,168)$87,448 
Subtract: Purchases of property and equipment18,123 16,249 64,668 70,338 
Free cash flow$(5,027)$35,182 $(76,836)$17,110 
 

Note - Our Adjusted EBITDA calculations and Free Cash Flow data are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.
GAAP - generally accepted accounting principles in the U.S.


Sleep Number Announces Third-quarter 2023 Results - Page 9 of 10    
SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Calculation of Net Leverage Ratio under Revolving Credit Facility
(in thousands)

Our calculation of Net Leverage Ratio under Revolving Credit Facility was changed effective with the amendment of our credit facility on November 2, 2023. Prior to the amendment, the calculation included capitalized operating lease obligations based on a multiple of six times annual rent expense. The amendment replaced this line item with operating lease liabilities included in our financial statements under ASC 842. The calculations in accordance with the credit facility prior to, and subsequent to, the November 2, 2023 amendment are presented below:
 
PRIOR TO AMENDMENT OF OUR CREDIT FACILITY ON NOVEMBER 2, 2023
 Trailing Twelve Months Ended
 September 30,
2023
October 1,
2022
Borrowings under revolving credit facility$488,000 $406,300 
Outstanding letters of credit7,147 5,947 
Finance lease obligations338 450 
Consolidated funded indebtedness$495,485 $412,697 
Capitalized operating lease obligations 1
679,224 650,742 
Total debt including capitalized operating lease obligations (a)$1,174,709 $1,063,439 
Adjusted EBITDA (see above)$131,798 $158,276 
Consolidated rent expense113,204 108,457 
Consolidated EBITDAR (b)$245,002 $266,733 
Net Leverage Ratio under revolving credit facility (a divided by b)4.8 to 1.04.0 to 1.0
1A multiple of six times annual rent expense is used as an estimate for capitalizing our operating lease obligations in accordance with our credit facility.

SUBSEQUENT TO AMENDMENT OF OUR CREDIT FACILITY ON NOVEMBER 2, 2023
 Trailing Twelve Months Ended
 September 30,
2023
October 1,
2022
Borrowings under revolving credit facility$488,000 $406,300 
Outstanding letters of credit7,147 5,947 
Finance lease obligations338 450 
Consolidated funded indebtedness$495,485 $412,697 
Operating lease liabilities 1
439,722 427,613 
Total debt including operating lease liabilities (a)$935,207 $840,310 
Adjusted EBITDA (see above)$131,798 $158,276 
Consolidated rent expense113,204 108,457 
Consolidated EBITDAR (b)$245,002 $266,733 
Net Leverage Ratio under revolving credit facility (a divided by b)3.8 to 1.03.2 to 1.0
1Reflects operating lease liabilities included in our financial statements under ASC 842.


Note - Our Net Leverage Ratio under Revolving Credit Facility, EBITDA and EBITDAR calculations are considered non-GAAP financial measures and are not in accordance with, or preferable to, "as reported," or GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts.
GAAP - generally accepted accounting principles in the U.S.





Sleep Number Announces Third-quarter 2023 Results - Page 10 of 10    
SLEEP NUMBER CORPORATION AND SUBSIDIARIES
Calculation of Return on Invested Capital (Adjusted ROIC)
(in thousands)
 
Adjusted ROIC is a financial measure we use to determine how efficiently we deploy our capital. It quantifies the return we earn on our adjusted invested capital. Management believes Adjusted ROIC is also a useful metric for investors and financial analysts. We compute Adjusted ROIC as outlined below. Our definition and calculation of Adjusted ROIC may not be comparable to similarly titled definitions and calculations used by other companies. The tables below reconcile adjusted net operating profit after taxes (Adjusted NOPAT) and total adjusted invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures:
 Trailing Twelve Months Ended
 September 30,
2023
October 1,
2022
Adjusted net operating profit after taxes (Adjusted NOPAT)  
Operating income$43,458 $81,625 
Add: Operating lease interest 1
27,497 25,419 
Less: Income taxes 2
(1,168)(24,306)
Adjusted NOPAT$69,787 $82,738 
  
Average adjusted invested capital
Total deficit$(420,687)$(437,471)
Add: Long-term debt 3
488,338 406,750 
Add: Operating lease liabilities 4
439,722 427,613 
Total adjusted invested capital at end of period$507,373 $396,892 
  
Average adjusted invested capital 5
$469,782 $371,674 
  
Adjusted ROIC 6
14.9 %22.3 %
1
Represents the interest expense component of lease expense included in our financial statements under ASC 842, Leases.
2
Reflects annual effective income tax rates, before discrete adjustments, of 1.6% and 22.7% for September 30, 2023 and October 1, 2022, respectively.
3
Long-term debt includes existing finance lease liabilities.
4
Reflects operating lease liabilities included in our financial statements under ASC 842.
5
Average adjusted invested capital represents the average of the last five fiscal quarters' ending adjusted invested capital balances.
6
Adjusted ROIC equals Adjusted NOPAT divided by average adjusted invested capital.
Note - the Company's adjusted ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, GAAP financial data. However, we are providing this information as we believe it facilitates analysis of the Company's financial performance by investors and financial analysts. The Company updated its Adjusted ROIC calculation effective beginning with the reporting period ended December 31, 2022, to reflect adjustments consistent with ASC 842. The prior period has been updated to reflect this calculation.
GAAP - generally accepted accounting principles in the U.S.


v3.23.3
Document and Entity Information
Nov. 02, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Nov. 02, 2023
Entity Registrant Name SLEEP NUMBER CORP
Entity Central Index Key 0000827187
Amendment Flag false
Entity Incorporation, State or Country Code MN
Entity File Number 000-25121
Entity Tax Identification Number 41-1597886
Entity Address, Address Line One 1001 Third Avenue South
Entity Address, City or Town Minneapolis
Entity Address, State or Province MN
Entity Address, Postal Zip Code 55404
City Area Code 763
Local Phone Number 551-7000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol SNBR
Security Exchange Name NASDAQ
Entity Emerging Growth Company false

Sleep Number (NASDAQ:SNBR)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Sleep Number Charts.
Sleep Number (NASDAQ:SNBR)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Sleep Number Charts.